A joint study between the Nursing School of North Henan Medical University (Xinxaing, China) and The First Affiliated Hospital of Harbin Medical University (Harbin, China) used gas chromatography–mass ...

Colorectal cancer highlights from ASCO 2025 include findings from the BREAKWATER, ATOMIC, DYNAMIC-III, and TRIPLETE trials.

Stepping into one of Makati Medical Center’s (MakatiMed) state-of-the-art operating suites feels like entering the future of ...

Physical activity after surgical resection for stage III colon cancer is associated with significantly longer disease-free survival.1 2 However, the biological mechanisms by which physical activity ...

SEATTLE — June 4, 2025 — Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news. Check out a video of Fred Hutch Advanced Practice Providers (APPs) ...

Patients with medium to high locally advanced rectal cancer who received short-course radiotherapy (SCRT) followed by 1 cycle of folinic acid, fluorouracil, and oxaliplatin (FOLFOX) and 7 cycles of ...

In a new multi-center study led by Boston University Chobanian & Avedisian School of Medicine, researchers have found that aggressive surgery in patients with advanced gallbladder cancer (T3 ...

The evidence-based British Thoracic Society (BTS) Guideline for pulmonary rehabilitation (PR) in adults was published in 2013.1 There is a strong evidence base for the benefits of PR,2 and it is one ...

Breast Cancer Combination Therapy Continues To Be Effective. Five years later, Beatriz is still on the triplet therapy as part of the phase 1 trial. She has tolerated the drugs well, and her cancer ...

Bladder cancer is the most common type of malignant tumor in the urinary system, which occurs in the bladder mucosa. Due to the lack of precise diagnostic tools, bladder cancer has a high recurrence ...

A sudden gurgling in his stomach sent him to the doctor. A CT scan revealed stage 4 colon cancer that had already spread. “We had to say, ‘your dad has cancer,’ and you know, we’re going to fight hard ...

The American Cancer Society (ACS) recommends PSA tests starting at age 50 for men who are at average risk for prostate cancer and are expected to live for at least 10 more years. Men who are age 45 ...